Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Tidefelt, U' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 29 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Mollgard, L; Hellberg, E; Smolowicz, A; Paul, C; Tidefelt, U
      Interactions between P-glycoprotein and drugs used in the supportive care of acute myeloid leukemia patients

      LEUKEMIA & LYMPHOMA
    2. Astrom, M; Bodin, L; Tidefelt, U
      Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population

      LEUKEMIA & LYMPHOMA
    3. Uggla, B; Mollgard, L; Stahl, E; Mossberg, LL; Karlsson, MG; Paul, C; Tidefelt, U
      Expression of topoisomerase II alpha in the G0/G1 cell cycle phase of fresh leukemic cells

      LEUKEMIA RESEARCH
    4. Tidefelt, U; Liliemark, J; Gruber, A; Liliemark, E; Sundman-Engberg, B; Juliusson, G; Stenke, L; Elmhorn-Rosenborg, A; Mollgard, L; Lehman, S; Xu, D; Covelli, A; Gustavsson, B; Paul, C
      P-glycoprotein inhibitor valspodar (PSC 833) increases the intracellular concentrations of daunorubicin in vivo in patients with p-glycoprotein-positive acute myeloid leukemia

      JOURNAL OF CLINICAL ONCOLOGY
    5. Mollgard, L; Tidefelt, U; Sundman-Engberg, B; Lofgren, C; Paul, C
      In vitro chemosensitivity testing in acute non lymphocytic leukemia using the bioluminescence ATP assay

      LEUKEMIA RESEARCH
    6. Persson, L; Vikerfors, T; Sjoberg, L; Engervall, P; Tidefelt, U
      Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    7. Astrom, M; Bodin, L; Nilsson, I; Tidefelt, U
      Treatment, long-term outcome and prognostic variables in 214 unselected AML patients in Sweden

      BRITISH JOURNAL OF CANCER
    8. Smolowicz, AG; Villman, K; Berlin, G; Tidefelt, U
      Kinetics of peripheral blood stem cell harvests during a single apheresis

      TRANSFUSION
    9. SUNDMANENGBERG B; PAUL C; TIDEFELT U
      EFFECT OF CYTOKINES ON THE TOXICITY OF CYTOSTATIC DRUGS TO NORMAL BONE-MARROW CELLS IN-VITRO

      Cancer chemotherapy and pharmacology
    10. SUNDMANENGBERG B; TIDEFELT U; PAUL C
      TOXICITY OF CYTOSTATIC DRUGS TO NORMAL BONE-MARROW CELLS IN-VITRO

      Cancer chemotherapy and pharmacology
    11. SMOLOWICZ AG; VILLMAN KA; TIDEFELT U
      RECRUITMENT OF CD34(-CELLS DURING A SINGLE APHERESIS AFTER MOBILIZATION BY CHEMOTHERAPY AND G-CSF())

      Bone marrow transplantation
    12. MOLLGARD L; TIDEFELT U; SUNDMANENGBERG B; LOFGREN C; LEHMAN S; PAUL C
      HIGH SINGLE-DOSE OF MITOXANTRONE AND CYTARABINE IN ACUTE NONLYMPHOCYTIC LEUKEMIA - A PHARMACOKINETIC AND CLINICAL-STUDY

      Therapeutic drug monitoring
    13. FERGEDAL M; ASTROM M; TIDEFELT U; KARLSSON MG
      DIFFERENCES IN CD14 AND ALPHA-NAPHTHYL ACETATE ESTERASE POSITIVITY AND RELATION TO PROGNOSIS IN AML

      Leukemia research
    14. SMOLOWICZ AG; VILLMAN K; TIDEFELT U
      LARGE-VOLUME APHERESIS FOR THE HARVEST OF PERIPHERAL-BLOOD PROGENITORCELLS FOR AUTOLOGOUS TRANSPLANTATION

      Transfusion
    15. MOLLGARD L; PRENKERT M; SMOLOWICZ A; LEHMAN S; TIDEFELT U
      FLOW-CYTOMETRY IN-VITRO CHEMOSENSITIVITY TESTING WITH PROPIDIUMIODID AND PHYCOERYTHRIN LABELED ANTIBODIES IN ACUTE NON LYMPHOCYTIC-LEUKEMIA

      Blood
    16. PAUL C; TIDEFELT U; GRUBER A; LILIEMARK E; SUNDMANENGBERG B; JULIUSSON G; STENKE L; ELMHORNROSENBORG A; MOLLGARD L; LEHMANN S; COVELLI A; MALKHANDI J; GUSTAVSSON B; LILIEMARK J
      THE P-GLYCOPROTEIN INHIBITOR (PGP) PSC-833 INCREASES THE INTRACELLULAR CONCENTRATIONS OF DAUNORUBICIN (DNR) IN-VIVO IN PATIENTS WITH PGP POSITIVE AML

      Blood
    17. JOHNSEN HE; BJORKSTRAND B; CARLSON K; GRUBER A; BLYSTAD A; FAST A; BOESEN AM; BJORKHOLM M; SALLERFORS B; RUUTU T; CARNESKOG J; MALM A; GEISLER C; LEHTINEN M; SCHRODER H; BRINCH L; REMES K; TIDEFELT U; HEILMANN C; HORNSTEN P; THORLING K; DAUGAARD G
      OUTCOME FOR PATIENTS WITH LEUKEMIA, MULTIPLE-MYELOMA AND LYMPHOMA WHORELAPSE AFTER HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL SUPPORT

      Leukemia & lymphoma
    18. SUNDMANENGBERG B; TIDEFELT U; PAUL C
      EFFECT OF CYTOKINES ON THE TOXICITY OF CYTOSTATIC DRUGS ON LEUKEMIC-CELLS IN-VITRO AND IN-VIVO

      European journal of haematology
    19. TIDEFELT U; PRENKERT R; PAUL C
      COMPARISON OF IDARUBICIN AND DAUNORUBICIN AND THEIR MAIN METABOLITES REGARDING INTRACELLULAR UPTAKE AND EFFECT ON SENSITIVE AND MULTIDRUG-RESISTANT HL-60 CELLS

      Cancer chemotherapy and pharmacology
    20. MOLLGARD L; PRENKERT M; SMOLOWICZ A; TIDEFELT U
      FLOW-CYTOMETRY IN-VITRO CHEMOSENSITIVITY TESTING WITH PROPIDIUMIODIDEAND PHYCOERYTHRIN LABELED ANTIBODIES IN ACUTE NON LYMPHOCYTIC-LEUKEMIA

      Blood
    21. LILIEMARK J; BJORKHOLM M; UDEN AM; HAST R; PAUL C; SIMONSSON B; TIDEFELT U; JULIUSSON G; HEDENUS M; EVENSEN S; TANGEN JM; SJO M; NESTHUS I; HESTDAL K
      A PHASE-I II STUDY OF SDZ PSC-833 (PSC) IN COMBINATION WITH DAUNORUBICIN (D) AND CYTARABINE IN REFRACTORY ACUTE MYELOGENOUS LEUKEMIA (AML)/

      Blood
    22. BJORKHOLM M; LILIEMARK J; GAHRTON G; GRIMFORS G; GRUBER A; HAST R; JULIUSSON G; JARNMARK M; KILLANDER A; KIMBY E; LERNER R; LJUNGMAN P; LONNQVIST B; PALMBLAD J; PAUL C; PETTERSON C; SIMONSSON B; STALFELT AM; STENKE L; SUNDSTROM C; TIDEFELT U; UDEN AM; OBERG G; OST A
      MITOXANTRONE, ETOPOSIDE AND ARA-C VS DOXORUBICIN-DNA, ARA-C, THIOGUANINE, VINCRISTINE AND PREDNISOLONE IN THE TREATMENT OF PATIENTS WITH ACUTE MYELOCYTIC-LEUKEMIA - A RANDOMIZED COMPARISON

      European journal of haematology
    23. GRUBER A; LILIEMARK E; TIDEFELT U; PAUL C; BJORKHOLM M; PETERSON C; LILIEMARK J
      PHARMACOKINETICS OF MITOXANTRONE, ETOPOSIDE AND CYTOSINE-ARABINOSIDE IN LEUKEMIC-CELLS DURING TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - RELATIONSHIP TO TREATMENT OUTCOME AND BONE-MARROW TOXICITY

      Leukemia research
    24. TIDEFELT U; PRENKERT M; PAUL C
      COMPARISON OF IDARUBICIN AND DAUNORUBICIN AND THEIR MAIN METABOLITES REGARDING INTRACELLULAR UPTAKE AND EFFECT ON SENSITIVE AND MULTIDRUG-RESISTANT HL-60 CELLS

      Blood
    25. JONSSON K; DAHLBERG N; TIDEFELT U; PAUL C; ANDERSSON G
      CHARACTERIZATION OF AN ANTHRACYCLINE-RESISTANT HUMAN PROMYELOCYTE LEUKEMIA (HL-60) CELL-LINE WITH AN ELEVATED MDR-1 GENE-EXPRESSION

      Biochemical pharmacology
    26. TIDEFELT U; JULIUSSON G; ELMHORNROSENBORG A; PETERSON C; PAUL C
      INCREASED INTRACELLULAR CONCENTRATIONS OF DOXORUBICIN IN RESISTANT LYMPHOMA-CELLS IN-VIVO BY CONCOMITANT THERAPY WITH VERAPAMIL AND CYCLOSPORINE-A

      European journal of haematology
    27. TIDEFELT U; SUNDMANENGBERG B; PAUL C
      COMPARISON OF THE INTRACELLULAR PHARMACOKINETICS OF DAUNORUBICIN AND IDARUBICIN IN PATIENTS WITH ACUTE-LEUKEMIA

      Leukemia research
    28. OSTERBORG A; BJORKHOLM M; BJOREMAN M; BRENNING G; CARLSON K; CELSING F; GAHRTON G; GRIMFORS G; GYLLENHAMMAR H; HAST R; JOHANSSON B; JULIUSSON G; JARNMARK M; KIMBY E; LERNER R; LINDEMALM C; LINDER O; OHRLING M; PAUL C; SIMONSSON B; SKARBERG KF; SMEDMYR B; STRANDER H; SVEDMYR E; TIDEFELT U; UDEN AM; WERNER B; OSBY E; MELLSTEDT H
      ALPHA-INTERFERON (WELLFERON), CYCLOPHOSPHAMIDE AND HIGH-DOSE BETAMETHASONE (CIB) FOLLOWED BY GM-CSF FOR TREATMENT OF MULTIPLE-MYELOMA - A PILOT-STUDY

      Blood
    29. SUNDMANENGBERG B; TIDEFELT U; GRUBER A; PAUL C
      INTRACELLULAR CONCENTRATIONS OF MITOXANTRONE IN LEUKEMIC-CELLS INVITRO VS INVIVO

      Leukemia research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 02/06/20 alle ore 20:52:53